|

Selective Sentinella Lymph Node Biopsy with Indocyanine Green in Patients with Breast Cancer

RECRUITINGSponsored by Omphis Foundation
Actively Recruiting
SponsorOmphis Foundation
Started2024-01-01
Est. completion2029-01-01
Eligibility
Age18 Years – 120 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT06378944

Summary

The current observational study aims to perform the sentinel lymph node in breast cancer in the usual way with technetium 99 and add a second tracer, indocyanine green. The objective is to evaluate the detection rate of the lymph node with indocyanine green compared to the usual technique.

Eligibility

Age: 18 Years – 120 YearsHealthy volunteers accepted
Inclusion Criteria:

* Patients \>18 years of age with breast cancer who are candidates for sentinel lymph node detection will be included.
* N0 patients or patients who have undergone target axillary detection with good response

Exclusion Criteria:

* Lymphadenectomy

Conditions2

Breast CancerCancer

Browse More Trials

Cancer trialsBreast Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.